NO166267C - Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet. - Google Patents
Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet.Info
- Publication number
- NO166267C NO166267C NO844017A NO844017A NO166267C NO 166267 C NO166267 C NO 166267C NO 844017 A NO844017 A NO 844017A NO 844017 A NO844017 A NO 844017A NO 166267 C NO166267 C NO 166267C
- Authority
- NO
- Norway
- Prior art keywords
- conjugate
- metal
- biologically active
- targesting
- sporable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 abstract 2
- 102000003792 Metallothionein Human genes 0.000 abstract 2
- 108090000157 Metallothionein Proteins 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO884941A NO173874C (no) | 1983-10-06 | 1988-11-04 | Konjugat til bruk ved fremstilling av spormerkede konjugater, bestaaende av et maalsoekende, biologisk aktivt molekyl og en forbindelse inneholdende et ikke-radioaktivt metall |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/539,733 US4732864A (en) | 1983-10-06 | 1983-10-06 | Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO844017L NO844017L (no) | 1985-04-09 |
| NO166267B NO166267B (no) | 1991-03-18 |
| NO166267C true NO166267C (no) | 1991-06-26 |
Family
ID=24152436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO844017A NO166267C (no) | 1983-10-06 | 1984-10-05 | Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4732864A (ja) |
| EP (1) | EP0137457B1 (ja) |
| JP (2) | JPS60166625A (ja) |
| KR (1) | KR860001151B1 (ja) |
| AT (1) | ATE32730T1 (ja) |
| AU (1) | AU578428B2 (ja) |
| CA (1) | CA1248090A (ja) |
| DE (1) | DE3469536D1 (ja) |
| DK (1) | DK162105C (ja) |
| ES (1) | ES8605105A1 (ja) |
| FI (1) | FI81263C (ja) |
| GR (1) | GR80560B (ja) |
| IE (1) | IE55709B1 (ja) |
| IL (1) | IL73183A (ja) |
| NO (1) | NO166267C (ja) |
| NZ (1) | NZ209788A (ja) |
| ZA (1) | ZA847797B (ja) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4707352A (en) * | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group |
| US4880626A (en) * | 1985-01-18 | 1989-11-14 | Mcmichael John | Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
| NO167124C (no) * | 1985-04-03 | 1991-10-09 | Du Pont Merck Pharma | Fremgangsmaate for fremstilling av et spormerket konjugat av metallthionein og biologisk aktivt molekyl. |
| US5776093A (en) * | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
| WO1987004351A1 (en) * | 1986-01-16 | 1987-07-30 | The General Hospital Corporation | Method for the diagnosis and treatment of inflammation |
| US5591581A (en) | 1986-04-30 | 1997-01-07 | Igen, Inc. | Electrochemiluminescent rhenium moieties and methods for their use |
| US6165729A (en) * | 1986-04-30 | 2000-12-26 | Hyperion Catalysis International, Inc. | Electrochemiluminescent reaction utilizing amine-derived reductant |
| US6451225B1 (en) | 1986-04-30 | 2002-09-17 | Igen International, Inc. | Electrochemiluminescent reaction utilizing amine-derived reductant |
| US4877599A (en) * | 1986-11-10 | 1989-10-31 | New England Deaconess Hospital Corporation | Detection of vascular disease with labelled antibodies |
| US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
| JP2538083B2 (ja) * | 1987-11-04 | 1996-09-25 | イゲン，インコーポレーテッド | 電気化学的ルミネッセンス性レニウムモイエティ及びそれらの使用方法 |
| US5202451A (en) * | 1988-02-17 | 1993-04-13 | Neorx Corporation | Anchimeric radiometal chelating compounds |
| USH735H (en) | 1988-03-30 | 1990-02-06 | The United States Of America As Represented By The United States Department Of Energy | Lead-203 as a label for radioimaging |
| US5061641A (en) * | 1988-04-01 | 1991-10-29 | Immunomedics, Inc. | Method for radiolabeling proteins |
| US5057301A (en) * | 1988-04-06 | 1991-10-15 | Neorx Corporation | Modified cellular substrates used as linkers for increased cell retention of diagnostic and therapeutic agents |
| US5059541A (en) * | 1988-04-29 | 1991-10-22 | Neorx Corporation | Minimal derivatization of proteins |
| US6702986B1 (en) | 1988-04-29 | 2004-03-09 | Igen International, Inc. | Electrochemiluminescent reaction utilizing amine-derived reductant |
| US5726153A (en) * | 1988-05-02 | 1998-03-10 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
| US5972890A (en) * | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
| US5218128A (en) * | 1988-06-15 | 1993-06-08 | Centocor, Inc. | Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom |
| WO1990006323A2 (en) * | 1988-11-29 | 1990-06-14 | Centocor, Inc. | Chimeric proteins incorporating a metal binding protein |
| US5443816A (en) * | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
| ATE172879T1 (de) * | 1989-08-09 | 1998-11-15 | Rhomed Inc | Direkte radioetikettierung von antikörpern und sonstigen proteinen mittels technetium oder rhenium |
| US5078985A (en) * | 1989-08-09 | 1992-01-07 | Rhomed, Incorporated | Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |
| US5985240A (en) * | 1989-08-09 | 1999-11-16 | Rhomed Incorporated | Peptide radiopharmaceutical applications |
| US5700444A (en) * | 1992-02-20 | 1997-12-23 | Rhomed Incorporated | Chemotactic peptide pharmaceutical applications |
| US5759515A (en) * | 1989-08-09 | 1998-06-02 | Rhomed Incorporated | Polyvalent peptide pharmaceutical applications |
| US5747334A (en) * | 1990-02-15 | 1998-05-05 | The University Of North Carolina At Chapel Hill | Random peptide library |
| SG65593A1 (en) * | 1990-02-15 | 1999-06-22 | Dana M Fowlkes | Totally synthetic affinity reagents |
| US5498538A (en) * | 1990-02-15 | 1996-03-12 | The University Of North Carolina At Chapel Hill | Totally synthetic affinity reagents |
| US7238340B1 (en) | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
| CA2101942C (en) * | 1991-02-08 | 2001-01-30 | Richard T. Dean | Technetium-99m labeled polypeptides for imaging |
| US5645815A (en) | 1991-02-08 | 1997-07-08 | Diatide, Inc. | Radiolabled compounds for thrombus imaging |
| US6019958A (en) * | 1991-02-08 | 2000-02-01 | Diatide, Inc. | Technetium-99m labeled peptides for imaging inflammation |
| US6403771B1 (en) | 1991-02-19 | 2002-06-11 | Actinium Pharmaceuticals, Limited | Method and means for site directed therapy |
| US6391590B1 (en) * | 1991-10-21 | 2002-05-21 | The Regents Of The University Of California | Recombinant streptavidin-metallothionein chimeric protein having biological recognition specificity |
| US5556609A (en) * | 1992-02-20 | 1996-09-17 | Rhomed Incorporated | YIGSR peptide radiopharmaceutical applications |
| US5738838A (en) * | 1992-02-20 | 1998-04-14 | Rhomed Incorporated | IKVAV peptide radiopharmaceutical applications |
| US5643549A (en) * | 1992-02-20 | 1997-07-01 | Rhomed Incorporated | Leukostimulatory agent for in vivo leukocyte tagging |
| US5326856A (en) * | 1992-04-09 | 1994-07-05 | Cytogen Corporation | Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
| US5338686A (en) * | 1992-04-29 | 1994-08-16 | Hellerstein Marc K | Method for measuring in vivo synthesis of biopolymers |
| CA2100709C (en) * | 1992-07-27 | 2004-03-16 | Maurits W. Geerlings | Method and means for site directed therapy |
| US6203775B1 (en) * | 1993-03-19 | 2001-03-20 | The General Hospital Corporation | Chelating polymers for labeling of proteins |
| CA2163107C (en) * | 1993-05-17 | 2001-04-17 | David Milton Goldenberg | Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| US6120768A (en) * | 1993-05-17 | 2000-09-19 | Immunomedics, Inc. | Dota-biotin derivatives |
| JPH09500140A (ja) * | 1993-07-19 | 1997-01-07 | レゾリューション・ファーマスーティカルズ・インコーポレーテッド | Ｎ▲下３▼ｓ立体配置を有するヒドラジノ型放射性核種キレート形成剤 |
| WO1995004753A1 (en) * | 1993-08-11 | 1995-02-16 | University Of New Mexico | Compositions of fusion proteins containing metallothionein and targeting-protein structural components |
| US5449761A (en) * | 1993-09-28 | 1995-09-12 | Cytogen Corporation | Metal-binding targeted polypeptide constructs |
| US5942210A (en) * | 1994-11-15 | 1999-08-24 | Cytogen Corporation | Methods for lyoprotecting a macromolecule using tricine |
| US5891418A (en) * | 1995-06-07 | 1999-04-06 | Rhomed Incorporated | Peptide-metal ion pharmaceutical constructs and applications |
| US6331285B1 (en) | 1996-06-05 | 2001-12-18 | Palatin Technologies, Inc. | Structurally determined cyclic metallo-constructs and applications |
| US7745142B2 (en) | 1997-09-15 | 2010-06-29 | Molecular Devices Corporation | Molecular modification assays |
| WO2000006243A2 (en) | 1998-07-28 | 2000-02-10 | Innerdyne, Inc. | Absorbable brachytherapy and chemotherapy delivery devices and methods |
| DE69926009D1 (de) * | 1998-10-13 | 2005-08-04 | Univ Georgia Res Found | Stabilisierte bioaktive peptide und methoden zu ihrer identifikation, synthese und verwendung |
| US20030190740A1 (en) * | 1998-10-13 | 2003-10-09 | The University Of Georgia Research Foundation, Inc | Stabilized bioactive peptides and methods of identification, synthesis, and use |
| US7666609B1 (en) * | 1998-12-01 | 2010-02-23 | Shanghai Cp Guojian Pharmaceutical Co. Ltd. | Method and composition for diagnosis of melanocytic lesions |
| AU2591800A (en) * | 1998-12-23 | 2000-07-31 | Bert L. Vallee | Synthetic and therapeutic methods for the alpha and beta domains of metallothionein |
| AU771248B2 (en) * | 1999-01-22 | 2004-03-18 | Martek Biosciences Corporation | Simple method for labeled conjugate production |
| ES2198171B1 (es) * | 2000-09-06 | 2005-04-16 | Provital, S.A. | Composicion cosmetica y/o farmaceutica conteniendo metalotioneina. |
| US7385025B2 (en) | 2000-12-19 | 2008-06-10 | Palatin Technologies, Inc. | Metallopeptide compounds |
| US20020117169A1 (en) | 2001-02-27 | 2002-08-29 | Kurz Daniel R. | Cover and applicator for a portion of a mammalian body |
| EP1395226A4 (en) * | 2001-06-11 | 2005-03-30 | Univ Miami | USE OF RADIOPHARMETHIC COMPLEXES TO IMPROVE TRANSPLANT TOLERANCE |
| DE60331827D1 (de) * | 2002-05-29 | 2010-05-06 | Immunomedics Inc | Zusammensetzungen für die radioimmuntherapie von gehirn-tumoren |
| JP2006502390A (ja) * | 2002-10-11 | 2006-01-19 | センティナ バイオテクノロジー インコーポレイテッド | 胸部癌の検出のための方法 |
| US20050232926A1 (en) * | 2003-06-06 | 2005-10-20 | Oncomax Acquisition Corp. | Antibodies specific for cancer associated antigen SM5-1 and uses thereof |
| CN1279056C (zh) * | 2003-06-06 | 2006-10-11 | 马菁 | 肿瘤相关抗原sm5－1的特异性抗体及其应用 |
| EP1675625B1 (en) | 2003-09-17 | 2013-02-20 | Board Of Regents, The University Of Texas System | Mechanism-based targeted pancreatic beta cell imaging |
| CA2550900A1 (en) | 2003-12-23 | 2005-07-07 | Mount Sinai Hospital | Methods for detecting markers associated with endometrial disease or phase |
| US7833731B2 (en) | 2004-03-31 | 2010-11-16 | Canon Kabushiki Kaisha | Gold-binding protein and use thereof |
| US20090239215A1 (en) * | 2004-12-16 | 2009-09-24 | Brandeis University | Clonable Tag for Purification and Electron Microscopy Labeling |
| US8765808B2 (en) * | 2005-03-23 | 2014-07-01 | Chs Pharma, Inc. | Treatment or prevention of cancer and precancerous disorders |
| WO2006102439A2 (en) * | 2005-03-23 | 2006-09-28 | Florida Atlantic University | Treatment or prevention of cancer and precancerous disorders |
| US8357720B2 (en) * | 2005-03-23 | 2013-01-22 | Florida Atlantic University | Treatment or prevention of cancer and precancerous disorders |
| WO2007130575A2 (en) * | 2006-05-03 | 2007-11-15 | Florida Atlantic University | Protection against oxidative damage in cells |
| GB0621894D0 (en) * | 2006-11-02 | 2006-12-13 | Iti Scotland Ltd | Magnetic recognition system |
| US20080269065A1 (en) * | 2007-04-30 | 2008-10-30 | Syntrix Biosystems, Inc. | Conformationally Constrained Analytical Probes |
| WO2008141318A1 (en) * | 2007-05-14 | 2008-11-20 | Dr. Susan Love Research Foundation | Device for determining risk of developing breast cancer and method thereof |
| CA2618163A1 (en) | 2008-02-07 | 2009-08-07 | K. W. Michael Siu | Head and neck cancer biomarkers |
| GB0808086D0 (en) * | 2008-05-02 | 2008-06-11 | Iti Scotland Ltd | Magnetic proteins for in vivo imaging |
| WO2009140408A2 (en) | 2008-05-13 | 2009-11-19 | University Of Kansas | Metal abstraction peptide (map) tag and associated methods |
| CN102596258B (zh) | 2009-07-22 | 2015-01-28 | 锕医药股份有限公司 | 用于制备放射性免疫缀合物的方法 |
| US10464987B2 (en) | 2009-10-06 | 2019-11-05 | Abbvie Inc. | Human single-chain T cell receptors |
| WO2012021969A1 (en) | 2010-08-16 | 2012-02-23 | Mount Sinai Hospital | Markers of the male urogenital tract |
| WO2013181461A2 (en) | 2012-06-01 | 2013-12-05 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
| EP3409297A1 (en) | 2017-05-30 | 2018-12-05 | AlfaRim Medial Holding B.V. | The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy |
| US20200230266A1 (en) | 2017-09-20 | 2020-07-23 | Alfarim Medical Holding B.V. | The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56125317A (en) * | 1980-03-08 | 1981-10-01 | Nippon Mejifuijitsukusu Kk | Stable radioactive diagnosticum with radioactive metallic mark |
| GB2109407B (en) * | 1981-10-27 | 1985-12-18 | Hybritech Inc | Tumour imaging with radiolabelled monoclonal antibodies |
| CA1222691A (en) * | 1981-12-29 | 1987-06-09 | Wilhelmus T. Goedemans | Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments |
| US4472509A (en) * | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
-
1983
- 1983-10-06 US US06/539,733 patent/US4732864A/en not_active Expired - Lifetime
-
1984
- 1984-09-28 AU AU33629/84A patent/AU578428B2/en not_active Ceased
- 1984-10-04 EP EP84111913A patent/EP0137457B1/en not_active Expired
- 1984-10-04 ZA ZA847797A patent/ZA847797B/xx unknown
- 1984-10-04 AT AT84111913T patent/ATE32730T1/de not_active IP Right Cessation
- 1984-10-04 GR GR80560A patent/GR80560B/el unknown
- 1984-10-04 DE DE8484111913T patent/DE3469536D1/de not_active Expired
- 1984-10-04 CA CA000464746A patent/CA1248090A/en not_active Expired
- 1984-10-05 DK DK480284A patent/DK162105C/da not_active IP Right Cessation
- 1984-10-05 NO NO844017A patent/NO166267C/no unknown
- 1984-10-05 ES ES536547A patent/ES8605105A1/es not_active Expired
- 1984-10-05 IE IE2539/84A patent/IE55709B1/en not_active IP Right Cessation
- 1984-10-05 FI FI843930A patent/FI81263C/fi not_active IP Right Cessation
- 1984-10-05 JP JP59208413A patent/JPS60166625A/ja active Granted
- 1984-10-05 NZ NZ209788A patent/NZ209788A/xx unknown
- 1984-10-05 IL IL73183A patent/IL73183A/xx not_active IP Right Cessation
- 1984-10-06 KR KR1019840006193A patent/KR860001151B1/ko not_active IP Right Cessation
-
1989
- 1989-04-04 JP JP1084174A patent/JPH01294700A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK162105B (da) | 1991-09-16 |
| ES8605105A1 (es) | 1986-02-16 |
| FI81263B (fi) | 1990-06-29 |
| AU3362984A (en) | 1985-04-18 |
| CA1248090A (en) | 1989-01-03 |
| ATE32730T1 (de) | 1988-03-15 |
| JPH01294700A (ja) | 1989-11-28 |
| IE842539L (en) | 1985-04-06 |
| IL73183A0 (en) | 1985-01-31 |
| IE55709B1 (en) | 1990-12-19 |
| ZA847797B (en) | 1986-05-28 |
| US4732864A (en) | 1988-03-22 |
| DK162105C (da) | 1992-02-17 |
| JPS60166625A (ja) | 1985-08-29 |
| NO166267B (no) | 1991-03-18 |
| NO844017L (no) | 1985-04-09 |
| FI843930L (fi) | 1985-04-07 |
| DK480284D0 (da) | 1984-10-05 |
| NZ209788A (en) | 1988-10-28 |
| ES536547A0 (es) | 1986-02-16 |
| EP0137457A2 (en) | 1985-04-17 |
| DK480284A (da) | 1985-04-07 |
| GR80560B (en) | 1985-02-06 |
| KR850002961A (ko) | 1985-05-28 |
| DE3469536D1 (en) | 1988-04-07 |
| FI843930A0 (fi) | 1984-10-05 |
| FI81263C (fi) | 1990-10-10 |
| EP0137457A3 (en) | 1985-08-14 |
| EP0137457B1 (en) | 1988-03-02 |
| AU578428B2 (en) | 1988-10-27 |
| IL73183A (en) | 1991-09-16 |
| KR860001151B1 (ko) | 1986-08-18 |
| JPH0470320B2 (ja) | 1992-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO166267C (no) | Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet. | |
| TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
| NO304552B1 (no) | Kompleksforbindelser, konjugater, farmas°ytiske preparater inneholdende slike og forbindelser | |
| AU7366687A (en) | Coupling agents for radiolabeling proteins | |
| KR950700749A (ko) | 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent) | |
| IT1212778B (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
| CA2093928A1 (en) | Monoclonal antibodies for detection and treatment of cancer | |
| HRP930239A2 (en) | Anti-inflamatory 4-aminophenol derivatives | |
| DK465488D0 (da) | Farmaceutisk praeparat indeholdende en triazol-forbindelse | |
| GR851767B (ja) | ||
| AU628095B2 (en) | Chelants possessing ortho ligating functionality and complexes thereof | |
| FR2707638B1 (fr) | Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique. | |
| DE3867086D1 (de) | Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen. | |
| OA07270A (fr) | Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique. | |
| ATE106732T1 (de) | Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung. | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 | |
| TR200000728T2 (tr) | Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı. | |
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| NO173874C (no) | Konjugat til bruk ved fremstilling av spormerkede konjugater, bestaaende av et maalsoekende, biologisk aktivt molekyl og en forbindelse inneholdende et ikke-radioaktivt metall | |
| IT1233861B (it) | Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antiinfiammatoria | |
| GEP19991402B (en) | Method of treatment of tube sterility of an inflammatory genesis | |
| KR970005296A (ko) | 편도선염 치료제 |